v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities    
Net loss $ (111,026,000) $ (23,742,000)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Stock-based compensation expense 3,770,000 7,543,000
Depreciation and amortization 12,115,000 12,320,000
Non-cash operating lease expense 625,000 735,000
Amortization of debt discount, issuance costs, and deferred financing costs 633,000 1,208,000
Investment discount and premium accretion (227,000) (914,000)
Provision for expected credit losses 555,000 810,000
Deferred tax provision 44,000 67,000
Impairment of goodwill 95,501,000 0
Other 229,000 (292,000)
Change in operating assets and liabilities:    
Accounts receivable, net (591,000) (6,067,000)
Prepaid expenses and other assets (33,000) 764,000
Accounts payable, accrued liabilities, and other liabilities 4,407,000 (7,196,000)
Deferred revenue 13,452,000 15,988,000
Operating lease liabilities (943,000) (944,000)
Net cash provided by operating activities 18,511,000 280,000
Cash flows from investing activities    
Proceeds from the sale and maturity of short-term investments 21,000,000 143,208,000
Purchase of short-term investments (24,915,000) 0
Acquisition of businesses, net of cash acquired 0 (41,122,000)
Capitalization of internal-use software (4,604,000) (4,661,000)
Purchase of property and equipment (338,000) (670,000)
Purchase of intangible assets (553,000) 0
Proceeds from the sale of property and equipment 4,000 7,000
Net cash (used in) provided by investing activities (9,406,000) 96,762,000
Cash flows from financing activities    
Proceeds from employee stock purchase plan 403,000 695,000
Repurchase of common stock 0 (5,000,000)
Repayment of debt (407,000) (407,000)
Net cash used in financing activities (4,000) (4,712,000)
Effect of exchange rate changes on cash and cash equivalents (51,000) (7,000)
Net increase in cash and cash equivalents 9,050,000 92,323,000
Cash and cash equivalents at beginning of period 50,814,000 249,645,000
Cash and cash equivalents at end of period 59,864,000 341,968,000
Supplemental disclosures of non-cash investing and financing information    
Common stock issued in connection with acquisitions 0 31,584,000
Stock-based compensation capitalized as internal-use software 198,000 244,000
Purchase of property and equipment included in accounts payable 38,000 188,000
Capitalized internal-use software included in accounts payable and accrued liabilities $ 212,000 $ 226,000